close-icon

MHQ: Clinical IntelligencePowered by SurvivorNet

  • health-panel

    Health Panel

  • clinical-trial

    Clinical Trials

    ?
Prefer to talk instead of typing?
close-icon

Answers offered are informational and do not constitute medical advice. Learn more

close-icon
Health Profile

Enter health info to personalize results.

What is your gender?

What is your age?

close-icon
Clinical Trials

clinical-icon

filter

Clear List

Ask me anything about your health...

I’m listening

thinking

responding

close-icon close-icon
close-icon
close-icon
close-icon
left-icon Back to Results

Dr. Randall Davis

location-icon

Bedford, TX

LOCATION OF PRACTICE
Baylor Scott & White Medical Center-grapevine
MEDICAL Specialty:

Marginal Zone Lymphoma, Multiple Myeloma, Osteosarcoma



1609 HOSPITAL PKWY, BEDFORD, TX, 760226920
PO BOX 911230, DALLAS, TX, 753911230
817-359-9096
NPI Number
1427091339
ABOUT

Randall Davis, MD, is a hematologist in Bedford, TX. He frequently treats conditions like Marginal Zone Lymphoma. Davis completed a fellowship at University of Iowa Hospitals & Clinics.

Dr. Randall Davis profile image

Published Articles

Analgesia and Imaging Practices in Pediatric Appendicitis: A 14-Year Retrospective Trend Analysis.- 2026 Apr 2
DASH-patterned groceries and effects on blood pressure in adults treated for hypertension: the GoFreshRx randomized trial.- 2026 Mar 28
Can We Predict Adductor Strain? A Predictive Analysis of a Major League Soccer (MLS) Cohort Spanning from 2019 to 2022.- 2026 Mar 5
Single droplet displacement infrared action spectroscopy.- 2026 Mar 26
Development and preliminary evaluation of the Implementation Research Proposal Appraisal Criteria (ImpResPAC) tool: an international expert modified e-Delphi study.- 2026 Mar 26
Empathic and agentic artificial intelligence in nursing: perspectives on a human-centered framework for cancer care navigation in the United States.- 2026 Jun
Determining size in an era when size matters: Interobserver comparison of CT lung tumor size measurements and accuracy of radiologic size estimation compared to pathologic size.- 2026 Mar 14
Prevention and postvention guidance relating to self-harm and suicide for UK educational and youth organisations: a systematic review of grey literature.- 2026 Mar 18
Québec Wildfires and Respiratory Emergency Department Visits in Charlottesville, Virginia.- 2026 Mar 18
Mutually exclusive alternative pre-mRNA splicing promotes adaptive metabolic stress signaling by JNK.- 2026 Mar 24

Clinical Trials

Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Brain Oxygen Optimization in Severe TBI, Phase 3
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial
Clairleafᵀᴹ: A Study to Test Long-term Treatment With BI 1291583 in People With Bronchiectasis Who Took Part in a Previous Study With This Medicine
Using Mentalization Based Therapy to Support Children and Adolescents Referred to Specialist Mental Health Services in the NHS for Aggressive and/or Violent Behaviour
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider